首页 | 本学科首页   官方微博 | 高级检索  
     


P53 and Beta-Catenin Activity during Estrogen treatment of Osteoblasts
Authors:Nalini?Chandar  author-information"  >  author-information__contact u-icon-before"  >  mailto:nchand@midwestern.edu"   title="  nchand@midwestern.edu"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Rasleen?Saluja,Peter?C?Lamar,Kevin?Kolman,Walter?C?Prozialeck
Affiliation:(1) Department of Biochemistry, Chicago College of Osteopathic Medicine, Midwestern University, 555, 31st Street, Downers Grove, IL 60515, USA;(2) Department of Pharmacology, Chicago College of Osteopathic Medicine, Midwestern University, 555, 31st Street, Downers Grove, IL 60515, USA
Abstract:

Background  

This study was undertaken to examine the relationship between the tumor suppressor gene p53 and the nuclear signaling protein beta-catenin during bone differentiation. Cross talk between p53 and beta-catenin pathways has been demonstrated and is important during tumorigenesis and DNA damage, where deregulation of beta catenin activates p53. In this study, we used estrogen treatment of osteoblasts as a paradigm to study the relationship between the two proteins during osteoblast differentiation.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号